Thomas Hartung

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 27

Top Venues

Archives of toxicology

Chemical research in toxicology

Advanced healthcare materials

Metabolites

Johns Hopkins University Bloomberg School of Public Health

Universitat Konstanz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins University Bloomberg School of Public Health Jan 01 2009

United States

Professor and Chair :: EHS CAAT

European Commission Joint Research Centre Ispra Sector Oct 01 2002 - Mar 31 2009

Italy

Head :: ECVAM

Universitat Konstanz Nov 01 1992 - Oct 01 2002

Germany

Assistant / Associate Professor :: Biochemical Pharmacology

Education History

Universitat Konstanz

Germany

PHD :: Biochemical Pharmacology

Publications

Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology 98 (3) (2024)
Fenna Sillé, Thomas Hartung
Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends. Metabolites 14 (2) (2024)
Fenna Sillé, Thomas Hartung
Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends. Metabolites 14 (2) (2024)
Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology 98 (3) (2024)
Gro H Mathisen, Angela Bearth, Lowenna B Jones, Sebastian Hoffmann, Gunn E Vist, Heather Melanie R Ames, Trine Husøy, Camilla Svendsen, Katya Tsaioun, Takao Ashikaga, Denise Bloch, Aleksandra Cavoski, Weihsueh A Chiu, Holly G Davies, Arianna Giusti, Thomas Hartung, Yoko Hirabayashi, Helena T Hogberg, Rashmi Joglekar, Hajime Kojima, Kannan Krishnan, Seok Kwon, Olivia J Osborne, Erwin Roggen, Andrew A Rooney, Christophe Rousselle, Jennifer B Sass, Ovnair Sepai, Ulla Simanainen, Kristina A Thayer, Weida Tong, Daniele S Wikoff, Fred A Wright, Paul Whaley
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Archives of toxicology 98 (8) (2024)
Lena Smirnova, Thomas Hartung
The Promise and Potential of Brain Organoids. Advanced healthcare materials (2024)
Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology 98 (3) (2024)
Lena Smirnova, Thomas Hartung
The Promise and Potential of Brain Organoids. Advanced healthcare materials 13 (21) (2024)
Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology (2024)
Gro H Mathisen, Angela Bearth, Lowenna B Jones, Sebastian Hoffmann, Gunn E Vist, Heather Melanie R Ames, Trine Husøy, Camilla Svendsen, Katya Tsaioun, Takao Ashikaga, Denise Bloch, Aleksandra Cavoski, Weihsueh A Chiu, Holly G Davies, Arianna Giusti, Thomas Hartung, Yoko Hirabayashi, Helena T Hogberg, Rashmi Joglekar, Hajime Kojima, Kannan Krishnan, Seok Kwon, Olivia J Osborne, Erwin Roggen, Andrew A Rooney, Christophe Rousselle, Jennifer B Sass, Ovnair Sepai, Ulla Simanainen, Kristina A Thayer, Weida Tong, Daniele S Wikoff, Fred A Wright, Paul Whaley
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Archives of toxicology 98 (8) (2024)
Lena Smirnova, Thomas Hartung
The Promise and Potential of Brain Organoids. Advanced healthcare materials (2024)
Fenna Sillé, Thomas Hartung
Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends. Metabolites 14 (2) (2024)
Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology 98 (3) (2024)
Gro H Mathisen, Angela Bearth, Lowenna B Jones, Sebastian Hoffmann, Gunn E Vist, Heather Melanie R Ames, Trine Husøy, Camilla Svendsen, Katya Tsaioun, Takao Ashikaga, Denise Bloch, Aleksandra Cavoski, Weihsueh A Chiu, Holly G Davies, Arianna Giusti, Thomas Hartung, Yoko Hirabayashi, Helena T Hogberg, Rashmi Joglekar, Hajime Kojima, Kannan Krishnan, Seok Kwon, Olivia J Osborne, Erwin Roggen, Andrew A Rooney, Christophe Rousselle, Jennifer B Sass, Ovnair Sepai, Ulla Simanainen, Kristina A Thayer, Weida Tong, Daniele S Wikoff, Fred A Wright, Paul Whaley
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology. Archives of toxicology (2024)
Nicole Kleinstreuer, Thomas Hartung
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine). Archives of toxicology 98 (3) (2024)
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, Anthony J Atala, Jeffrey T Borenstein, Kyle R Brimacombe, Sara Cherry, Hans Clevers, Mindy I Davis, Simon G P Funnell, Lee Gehrke, Linda G Griffith, Abigail C Grossman, Thomas Hartung, Donald E Ingber, Nicole C Kleinstreuer, Calvin J Kuo, Emily M Lee, Christine L Mummery, Thames E Pickett, Sasirekha Ramani, Edwin A Rosado-Olivieri, Evi Budo Struble, Zhengpeng Wan, Mark S Williams, Matthew D Hall, Marc Ferrer, Sarine Markossian
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. The Journal of infectious diseases (2023)
Fenna C M Sillé, Meredith C McCormack, Thomas Hartung
The Exposome Applied: A Step toward Defining the Totality of Environmental Exposures in Asthma. American journal of respiratory and critical care medicine 206 (10) (2022)
Qi Huang, Bohao Tang, July Carolina Romero, Yuqian Yang, Saifeldeen Khalil Elsayed, Gayatri J Pahapale, Tien-Jung Lee, Itzy E Morales Pantoja, Fang Han, Cynthia A Berlinicke, Terry Xiang, Mallory Solazzo, Thomas Hartung, Zhao Qin, Brian S Caffo, Lena Smirnova, David H Gracias
Shell microelectrode arrays (MEAs) for brain organoids. Science advances 8 (33) (2022)
Alexandra Maertens, Emily Golden, Thomas Hartung
Avoiding Regrettable Substitutions: Green Toxicology for Sustainable Chemistry. ACS sustainable chemistry & engineering 9 (23) (2021)
Anne M Evans, Claire O'Donovan, Mary C Playdon, Christopher Beecher, Richard D Beger, John A Bowden, David I Broadhurst, Andrew T Chan, Surendra Dasari, Warwick B Dunn, Julian Leether Griffin, Thomas Hartung, Ping- Ching Hsu, Tao Huan, Judith J M Jans, Christina M Jones, Maureen Kachman, Andre Kleensang, Matthew R Lewis, María Eugenia Monge, Jonathan D Mosley, Eric B Taylor, Fariba Tayyari, Georgios A Theodoridis, Federico T Torta, Baljit K Ubhi, Dajana Vuckovic, null null
Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners. Metabolomics : Official journal of the Metabolomic Society 16 (10) (2020)
Simon Plummer, Stephanie Wallace, Graeme Ball, Roslyn Lloyd, Paula Schiapparelli, Alfredo Quiñones-Hinojosa, Thomas Hartung, David Pamies
A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine. Scientific reports 9 (1) (2019)
Thomas Luechtefeld, Craig Rowlands, Thomas Hartung
Big-data and machine learning to revamp computational toxicology and its use in risk assessment. Toxicology research 7 (5) (2018)
Thomas Hartung, Robert Kavlock, Shana J Sturla
Systems Toxicology II: A Special Issue. Chemical research in toxicology 30 (4) (2018)
Thomas Hartung, Rex E FitzGerald, Paul Jennings, Gary R Mirams, Manuel C Peitsch, Amin Rostami-Hodjegan, Imran Shah, Martin F Wilks, Shana J Sturla
Systems Toxicology: Real World Applications and Opportunities. Chemical research in toxicology 30 (4) (2017)
Aleksander Skardal, Sean V Murphy, Mahesh Devarasetty, Ivy Mead, Hyun-Wook Kang, Young-Joon Seol, Yu Shrike Zhang, Su-Ryon Shin, Liang Zhao, Julio Aleman, Adam R Hall, Thomas D Shupe, Andre Kleensang, Mehmet R Dokmeci, Sang Jin Lee, John D Jackson, James J Yoo, Thomas Hartung, Ali Khademhosseini, Shay Soker, Colin E Bishop, Anthony Atala
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Scientific reports 7 (1) (2017)
Leslie Myint, Andre Kleensang, Liang Zhao, Thomas Hartung, Kaspar D Hansen
Joint Bounding of Peaks Across Samples Improves Differential Analysis in Mass Spectrometry-Based Metabolomics. Analytical chemistry 89 (6) (2017)
David Pamies, Thomas Hartung
21st Century Cell Culture for 21st Century Toxicology. Chemical research in toxicology 30 (1) (2016)

Thomas Hartung.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Hartung